Interleukins in Atherosclerosis: Molecular Pathways and Therapeutic Potential

@article{Thsen2003InterleukinsIA,
  title={Interleukins in Atherosclerosis: Molecular Pathways and Therapeutic Potential},
  author={J. H. von der Th{\"u}sen and J. Kuiper and T. V. van Berkel and E. Biessen},
  journal={Pharmacological Reviews},
  year={2003},
  volume={55},
  pages={133 - 166}
}
Interleukins are considered to be key players in the chronic vascular inflammatory response that is typical of atherosclerosis. Thus, the expression of proinflammatory interleukins and their receptors has been demonstrated in atheromatous tissue, and the serum levels of several of these cytokines have been found to be positively correlated with (coronary) arterial disease and its sequelae. In vitro studies have confirmed the involvement of various interleukins in pro-atherogenic processes, such… Expand
Pro- and Anti-Inflammatory Cytokine Networks in Atherosclerosis
Cytokines and atherosclerosis: a comprehensive review of studies in mice
Attenuation of Experimental Atherosclerosis by Interleukin-19
Novel control of cAMP-regulated transcription in vascular endothelial cells.
Anti-Inflammatory Effects of Interleukin-19 in Vascular Disease
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 710 REFERENCES
IL-10: An "immunologic scalpel" for atherosclerosis?
  • R. Terkeltaub
  • Medicine
  • Arteriosclerosis, thrombosis, and vascular biology
  • 1999
Protective role of interleukin-10 in atherosclerosis.
Cytokines Regulate Vascular Functions Related to Stability of the Atherosclerotic Plaque
Endothelin Antagonism and Interleukin-6 Inhibition Attenuate the Proatherogenic Effects of C-Reactive Protein
Anti-Inflammatory Mechanisms in the Vascular Wall
Reduction of atherosclerosis in mice by inhibition of CD40 signalling
Expression of Interleukin-18 in Human Atherosclerotic Plaques and Relation to Plaque Instability
  • Ziad Mallat, Anne Corbaz, +4 authors Alain Tedgui
  • Medicine
  • Circulation
  • 2001
...
1
2
3
4
5
...